Stay updated with breaking news from Gencor Pacific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New research has concluded Levagen+ palmitoylethanolamide (PEA) could provide an innovative intervention for cognitive health enhancement in students, opening a door to the gaming market for Gencor Pacific Ltd.
With the NutraIngredients Awards celebrating its 10 year anniversary in 2024, we speak to winners from the last decade and find out how their award win has impacted their business.
A new study suggests that Gencor Pacific’s Levagen+ Palmitoylethanolamide (PEA) ingredient may alleviate symptoms of seasonal allergies as shown by a reduction in histamine and inflammatory markers despite a strong placebo effect.
A new study suggests that Gencor Pacific’s Levagen+ Palmitoylethanolamide (PEA) ingredient may alleviate symptoms of seasonal allergies as shown by a reduction in histamine and inflammatory markers despite a strong placebo effect.
Palmitoylethanolamide (PEA) is a safer and more pervasive therapeutic alternative to cannabidiol, say the authors of the Gencor Pacific-commissioned review, ‘Palmitoylethanolamide: A Potential Alternative to Cannabidiol.’